Human Therapeutic IgG2 ELISA Kit, Cayman Chemical Company

Supplier: Cayman Chemical
500960-96
75816-824EA 899.74 USD
75816-824
Human Therapeutic IgG2 ELISA Kit, Cayman Chemical Company
Assays ELISAs
A generic assay for the quantitation of therapeutic human IgG2 antibodies in monkey serum or plasma.

  • Specifically detect human IgG2 antibodies in monkey plasma or serum
  • Not cross-reactive to rhesus or cynomolgus immunoglobulins
  • Useful for pharmacokinetic analysis of therapeutic human IgG2 antibodies in monkeys
  • Useful for detecting human IgG2 in mouse or rat plasma or serum

Human therapeutic antibodies have become increasingly common components of early drug discovery and development portfolios in the pharmaceutical and biotech industries. As part of preclinical toxicology assessment of these agents, they are routinely tested in non-human primates, primarily in rhesus or cynomolgus monkeys. In order to assess the pharmacokinetics of the human antibodies in monkey serum, it is necessary to have an assay that is capable of distinguishing the experimentally-introduced human IgG from the endogenous monkey IgG. Cayman’s Human Therapeutic IgG2 ELISA Kit is an immunometric assay which can be used to measure human IgG2 in monkey or rodent plasma and serum without prior sample purification. The standard curve spans the range of 3.13-200 ng/ml, with an LLOQ of 3.13 ng/ml. The assay has been validated in sera from rats and cynomolgus monkeys.

Delivery information: Kit contains: Standard, HRP-Conjugate, Buffers, Reagents, and precoated 96-well Plate
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR